Month: September 2021

Small Pharma’s Peter Rands, CEO, and Carol Routledge, CMSO, to address virtual conference exploring the potential of DMT on September 9 and 10, 2021 LONDON, Sept. 08, 2021 (GLOBE NEWSWIRE) — Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, announces that it will headline Microdose’s virtual 2021 DMT Conference as one of the event’s lead sponsors. The conference, taking place on September 9 and 10, will bring together some of the world’s leading industry figures exploring the potential of N,N-dimethyltryptamine (DMT) at the intersection of drug development and safety, clinical care and applications, law and regulation, business and markets, science and research as well as history and culture. Peter Rands, Small Pharma’s CEO, will deliver a keynote...

SALT LAKE CITY, Sept. 08, 2021 (GLOBE NEWSWIRE) — omniQ Corp. (NADSAQ: OMQS) (“omniQ ” or “the Company”), a provider of object identification, automation and Artificial Intelligence (AI)-based solutions, to the Supply Chain Automation, Traffic Management, Public Safety, Public Health, retail and Safe City markets, announced today that management will participate in Lake Street Capital Markets’ 5th Annual Best Ideas Growth (BIG5) Conference on September 14, 2021. To learn more about the event or to schedule a one-on-one meeting with management, please contact your conference representative or james@haydenir.com. About omniQ Corp.omniQ Corp. (NASDAQ: OMQS) provides computerized and machine vision image processing solutions that use patented and proprietary AI technology to deliver data collection, real-time surveillance and monitoring...

VANCOUVER, British Columbia, Sept. 08, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pure Extracts Manufacturing Corp., has shipped its initial order via its distribution partner to the Ontario Cannabis Store (OCS), establishing the Company’s presence in Eastern Canada. Pure Extracts’ Pure Pulls CBD vape cartridges will soon be available for purchase through the OCS’ online store and through licensed, private retailers throughout the province. The shipment is for 1 gram, full spectrum oil (FSO), CBD vape cartridges. This product has been created by Pure Extracts...

Automated Coding Analysis for Inpatient and Outpatient Care Atlanta, GA, Sept. 08, 2021 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively revenue leakage and financial performance, today announced it has signed a contract with a Cerner EHR-based health system located in Eastern North Carolina. The nearly 300-bed medical center will use eValuator’s automated pre- and post-bill coding analysis technology to help improve revenue integrity and financial performance from their inpatient and outpatient services. Streamline Health is leading an industry movement to enable every hospital in the country to use pre-bill technology to improve financial performance. With eValuator, providers are identifying and addressing coding...

Figure 1Plan view of Selected Drill Holes at MercedesFigure 2Plan view of Mercedes and Selected Results of Underground Mapping and Channel SamplingFigure 3Cross Section EW 7,437,725 (Drill holes MER-12 and MER-14)Figure 4Cross Section EW 7,437,600 (Drill holes MER-12 and MER-14)Figure 5Map of MOD Resource and Near MOD Exploration TargetsVANCOUVER, British Columbia, Sept. 08, 2021 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce that reverse circulation (“RC”) drilling completed at the Mercedes Target (“Mercedes”), has intersected significant oxide copper mineralization from surface, with an initial area of interest measuring 400m along strike and 300m width. A total of 17 holes were...

Figure 1Figure 1 illustrates the proximity of the three deposits which are 100% owned by Adyton ResourcesFigure 2Figure 2 illustrates recent drilling locationsFigure 3Figure 3 illustrates cross section reported on holes 1 to 3Figure 4Figure 4 illustrates cross section reported on holes 4 to 5About AdytonMap showing the location of Adyton’s Papua New Guinea exploration projects relative to significant PNG gold projects26m @ 1.79g/t Au, incl 9m @ 2.94g/t Au and 4m @ 3.16g/t AuBRISBANE, Australia, Sept. 08, 2021 (GLOBE NEWSWIRE) — Adyton Resources Corporation (TSX Venture: ADY) (“Adyton”) Highlights:Results from Adyton’s maiden diamond drilling at its 100% owned Wapolu deposit exceeded historical drilling results. Significant intersections...

CEO Carl Wolf to Present Virtually September 13th EAST RUTHERFORD, NJ, Sept. 08, 2021 (GLOBE NEWSWIRE) — MamaMancini’s Holdings, Inc. (NASDAQ: MMMB), a marketer of specialty pre-prepared, frozen and refrigerated food products, today announced that management will present at the Taglich Brothers 17th Annual Investment Conference taking place September 13-14, 2021 at the TWA Hotel in New York. Carl Wolf, Chairman and Chief Executive Officer of MamaMancini’s, is scheduled to host a virtual presentation during the conference as follows: Taglich Brothers 17thAnnual Investment ConferenceDate: Monday, September 13, 2021Time: 9:45 a.m. Eastern time Webcast: https://www.webcaster4.com/Webcast/Page/2049/42732 A live audio webcast and archive of the event presentation will be available using the webcast link above. For more information...

PHOENIX, Sept. 08, 2021 (GLOBE NEWSWIRE) — Global Water Resources, Inc. (NASDAQ: GWRS), (TSX: GWR), a pure-play water resource management company, has been invited to present at the Janney Water Utilities Conference being held virtually on Tuesday, September 14, 2021. Global Water Resource’s CEO, Ron Fleming, is scheduled to present in one-on-one virtual meetings with institutional analysts and investors throughout the day. He will be joined by the company’s SVP and CFO, Mike Liebman, and chief strategy officer, Chris Krygier. Management will discuss the company’s growth strategy, which includes expanding service areas through organic growth in connections as well as acquisition of other utilities. Over the last year, the company has agreed to acquire six utilities in Arizona, and plans to make additional acquisitions this year. Submit...

NEW YORK, Sept. 08, 2021 (GLOBE NEWSWIRE) — Logiq, Inc. (NEO: LGIQ) (OTCQX: LGIQ), a global provider of award-winning e-commerce and fintech solutions, has partnered with IRIS.TV, the leading video data platform, to utilize IRIS_ID, a unique global identifier assigned to individual videos, to provide greater transparency and performance in streaming video for e-commerce marketers. This partnership enables contextual and brand-safe connected-TV (or “CTV”) targeting for e-commerce marketing programs, as CTV continues to be one of the fastest-growing advertising platforms. Connected TV refers to premium content streaming through apps, either on a smart TV or through an over-the-top device. eMarketer reported in a recent CTV programmatic advertising update that incremental spending on programmatic CTV video ads in 2021 will increase...

Proposed Phase 1b/2a clinical trial designed to determine safety and potential efficacy of oral and topical FW-420 BOCA RATON, Fla., Sept. 08, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today the submission of an Investigational New Drug (IND) Application seeking permission from the U.S. Food and Drug Administration (FDA) to begin a clinical trial evaluating proprietary formulations of niclosamide for Grade 1 and Grade 2 colitis and diarrhea in oncology patients receiving treatment with immune checkpoint inhibitors (ICIs). The planned Phase 1b/2a clinical trial, now known as PASSPORT, is designed to determine the safety and potential...